Identification of two major loci that suppress hearing loss and cochlear dysmorphogenesis in Eya1bor/bor mice  by Niu, Haoru et al.
6) 302–308
www.elsevier.com/locate/ygenoGenomics 88 (200Identification of two major loci that suppress hearing loss and
cochlear dysmorphogenesis in Eya1bor/bor mice
Haoru Niu, Linna Makmura, Ted Shen, Sonal S. Sheth, Kate Blair, Rick A. Friedman ⁎
Gonda Cell and Molecular Biology Research Laboratories, House Ear Institute, 2100 W. Third Street, Los Angeles, CA 90057, USA
Received 29 December 2005; accepted 19 January 2006
Available online 20 February 2006Abstract
The Eya1bor mutant hypomorph contains an intracisternal A particle insertion in intron 7 of the Eya1 gene that results in a 50% reduction in
wild-type mRNA levels. The homozygous mutants have middle and inner ear defects and variable kidney abnormalities. The severity of the
disorder is affected by genetic background. In contrast to complete deafness and cochlear agenesis in the C3HeB/FeJ strain, F2 Eya1bor/bor mutants
from an intercross between C3HeB/FeJ-Eya1bor/+ and C57BL/6J showed variable auditory brain-stem responses and cochlear coiling. In this
study, using these F2 Eya1bor/bor mutants, we have identified two major loci, Mead1 (modifier of Eya1-associated deafness 1) and Mead2, that are
responsible for suppression of the original phenotypes. We have narrowed these two loci to 5.4 and 4.4 cM, respectively, in congenic lines.
Quantitative PCR demonstrated that this modifying effect did not result from an increase in wild-type Eya1 mRNA, suggestingMead1 andMead2
are interacting directly or indirectly with Eya1 during inner ear development.
© 2006 Elsevier Inc. All rights reserved.Keywords: Branchio–oto–renal syndrome; Eya1; Modifier; Hearing loss; Auditory brain-stem response; Cochlea morphology; Quantitative trait lociGenetic factors account for more than half of congenital
deafness disorders. To date, more than 120 genes underlying
many of these disorders have been identified. Hereditary
hearing loss is classified by the presence or absence of clinical
features associated with the deafness; two broad classes are
nonsyndromic, in which hearing loss occurs in isolation, and
syndromic, in which hearing loss occurs in association with
other clinical features.
Branchio–oto–renal (BOR) syndrome (OMIM 113650) is
one form of syndromic hearing loss that was described by
Melnick et al. in 1976 [1]. Their study reported a family with a
father and three children exhibiting mixed hearing loss, cochlear
malformation, stapes fixation, preauricular pits, branchial cleft
fistulae, and renal dysplasia. The clinical features of this
disorder vary significantly, particularly in the severity of
hearing loss and renal abnormalities, suggesting that other
factors, genetic or environmental, may be impacting penetrance
and expressivity.⁎ Corresponding author.
E-mail address: rfriedman@hei.org (R.A. Friedman).
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doi:10.1016/j.ygeno.2006.01.005Based upon its vertical transmission pattern, BOR syndrome
has been categorized as an autosomal dominant disorder for
which the underlying genes, Eya1 and SIX1, have been
identified [2,3]. The mechanisms by which mutations in these
genes induce these phenotypes and their roles in the normal
development of these organs are poorly understood. Xu et al. [4]
reported on the generation of a mouse model of BOR syndrome
by disrupting the endogenous Eya1 gene through homologous
recombination. These mice had developmental anomalies in
multiple organs, including the outer, middle, and inner ear; the
kidneys [4]; and organs derived from the branchiomeric
apparatus such as the thymus and the parathyroid and thyroid
glands [5]. We [6] reported a novel mutant (Eya1bor/bor) with a
BOR-like phenotype resulting from an intracisternal A particle
(IAP) insertion into intron 7 of the Eya1 gene. The homozygous
mutant hypomorphs displayed a characteristic waltzing pheno-
type associated with inner ear dysmorphogenesis and kidney
anomalies. The phenotypic expression of the Eya1bor mutation
was dramatically affected by the genetic background, suggest-
ing the existence of modifier quantitative trait loci (QTLs) in
other strains. Specifically, postnatal survival and severity of
Fig. 1. Distribution of hearing thresholds and cochlear turns for F2 Eya1bor/bor
mice from the C57BL/6J × C3HeB/FeJ-Eya1bor/+ intercross. (A) Hearing
thresholds. A total of 267 mice were used for the analysis. Mice with thresholds
higher than 90 dB were considered deaf. (B) Cochlea turns. 89 mice from the
267 in (A) were used for the analysis.
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providing an ideal model for the human disease.
The identification of genetic modifiers is a well-established
and powerful tool for the elucidation of complex genetic
interactions in bacteria, yeast, nematodes, and Drosophila.With
the introduction of QTL analysis [7], the identification of
genetic modifiers in mice has become practical and informative.
In a recent study, we showed that one such modifier gene,
nuclear export factor (Nxf1), suppressed the mortality and the
deafness in F2 Eya1bor/bor mutants from a C3HeB/FeJ and
CAST/Ei intercross by increasing normal Eya1 mRNA levels
[8]. In this study, we describe two QTLs and designate these loci
as “modifier of Eya1-associated deafness” or Mead1 on
chromosome 4 and Mead2 on chromosome 12. We show that
Mead1 and Mead2 suppress the Eya1bor deafness phenotype,
including cochlear dysmorphogenesis and hearing loss, and
demonstrate the potential significance of modifier genes in the
variable expressivity associated with BOR syndrome.
Results
QTL mapping of Mead1 and Mead2 loci based on ABR
thresholds
To identify novel QTLs that modify the Eya1bor phenotype,
we generated Eya1bor/bor F2 mice by mating Eya1bor/+ F1
hybrids resulting from a C3HeB/FeJ-Eya1bor/+ and C57BL/6J-
Eya1+/+ intercross. Of 2255 F2 mice generated, 267 mice were
Eya1bor/bor (referred to as F2-Eya1bor/bor). This indicates a 60%
prenatal death rate (392 of 659). In comparison, the Eya1bor/bor
mice on the original C3HeB/FeJ background had a prenatal
death rate of 85% (304 of 356).
Auditory brain-stem response (ABR) thresholds were
obtained on all 267 F2-Eya1bor/bor mice using a broadband
click stimulus. Unlike the deafness uniformly seen in the
C3HeB/FeJ-Eya1bor/bor mice, 52% of the F2-Eya1bor/bor (139/
267) exhibited detectable responses in at least one ear at thres-
holds varying from 35 to 90 dB (Fig. 1A). In comparison, 9 F2-
Eya1bor/+ and 9 F2-Eya1+/+ exhibited normal hearing with an
average ABR threshold of 23 ± 2 (mean ± SD) and 22 ± 3 dB,
respectively. These values were comparable to those observed in
strains C3HeB/FeJ-Eya1+/+ (37 ± 2 dB), C57BL/6J (42 ± 3 dB),
and (C3HeB/FeJ-Eya1bor/+ × C57BL/6J)F1 (19 ± 3 dB). The
large variation in ABR thresholds was observed only in mice
homozygous for the Eya1bor mutation, suggesting the existence
of genetic factors that specifically interact with Eya1bor in inner
ear development.
Each of the 267 F2-Eya1bor/bor mice was genotyped using 93
microsatellite markers distributed across the entire genome.
Two loci highly associated with the click ABR thresholds were
identified. The first locus, Mead1, associated with marker
D4Mit104 on chromosome 4, demonstrated a lod score of 12.0
and explained 19% of the variation in hearing (Fig. 2A, dashed
line). The second locus, Mead2, associated with marker
D12Mit283 on chromosome 12, demonstrated a lod score of
12.1 and explained 19% of the variation in hearing (Fig. 2B,
dashed line).QTL mapping of Mead1 and Mead2 based upon cochlear
coiling
The wild-type mouse cochlea has 1 3/4 turns (Fig. 3A).
However, in the C3HeB/FeJ-Eya1bor/bor mice, cochlear
agenesis is one of the most consistent phenotypes (Fig. 3B).
We examined cochlear coiling in 89 of the F2-Eya1bor/bor
mice mentioned above and observed a C57BL/6J modifying
effect on cochlear coiling, as well. In contrast to the C3HeB/
FeJ-Eya1bor/bor mice that have no cochlear coiling, the
cochlear turns in the F2-Eya1bor/bor mice varied from agenesis
to the normal 1 3/4 turns (Figs. 1 and 3B–E). We performed
QTL analysis using cochlear turns as quantitative trait and
identified two major loci that overlapped with the hearing
QTLs, Mead1 and Mead2. The first locus on chromosome 4
was linked to marker D4Mit104 based on the cochlear coiling
phenotype with a LOD = 15.8 and explained 56% of the
variation (Fig. 2A, solid line). Similarly for the second locus,
marker D12Mit283 was linked with cochlear coiling
(LOD = 3.3) and explained 16% of the variation (Fig. 2B,
solid line). These data suggest that the same two genes within
the Mead1 and Mead2 critical regions modify hearing and
cochlear coiling.
Generation of congenic lines
To fine-map the critical regions of Mead1 and Mead2
and to identify potential candidate genes, we developed
Fig. 2. The lod score distribution for associations of ABR thresholds and
cochlear turns at the two loci: (A)Mead 1 on chromosome 4 and (B)Mead 2 on
chromosome 12. In (B), the y axis on the left represents the lod score for ABR
thresholds and on the right, cochlear turns.
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with the C57BL/6J allele covering the 95% confidence
interval at the Mead1 and Mead2 loci, respectively, by a
marker-assisted breeding approach (see Materials and
methods, Mouse crosses). Eya1bor/+ mice were chosen for
breeding in each step, so that Eya1bor/bor mutants could be
generated and evaluated in each generation. We noticed that
suppression of the hearing loss in these congenic Eya1bor/bor
mice gradually diminished and eventually was lost as the
C57BL/6J genomic contribution was reduced. We hypothe-
sized that it needed multiple modifier loci or alleles for
hearing rescue to occur. The cochlear coiling modification
persisted, however.
Eya1bor/bor mice consistently exhibited 1/2–3/4 cochlear
turn, when heterozygous for C57BL/6J Mead1 allele
between markers D4Mit149 and D4Mit193 (14 samples),
and 1 to 1 1/4 turns when homozygous for this same region
(11 samples). These findings were consistent with a
Mendelian semidominant inheritance pattern with complete
penetrance. Consistent with the enhanced cochlear morphol-
ogy seen in the six mutants analyzed carrying two C57BL/
6J Mead1 alleles, we recorded ABR thresholds of 70–85 dB
in each. By measuring cochlear turns in the Eya1bor/bor
congenic mice heterozygous for C57BL/6J Mead1 allele, wewere able to narrow down the Mead1 region to 5.4 cM
between markers D4Mit227 and D4Mit171 (as shown in
Fig. 4A).
Sixteen percent (4/25) of the Eya1bor/bor mice formed
more than 1/4 cochlear turn when heterozygous for the
C57BL/6J Mead2 allele between markers D12Mit103 and
D12Mit172 and 1/2–3/4 turn when homozygous for this
region. Again, a Mendelian semidominant pattern of
inheritance was noted; however, Mead2 demonstrated
incomplete penetrance (16%) in heterozygotes and complete
penetrance in the homozygotes. By measuring cochlear turns
in the Eya1bor/bor mice homozygous for the C57BL/6J
Mead2 allele, we were able to narrow the critical region to
4.4 cM between markers D12Mit56 and D12Mit283 (as
shown in Fig. 4B).
Eya1 expression in congenic strains
We next set out to determine whether the levels of Eya1
expression in the congenic embryos (E10.5) were affected by
the C57BL/6J alleles of Mead1 and Mead2. Eya1 was highly
expressed in otocyst, spiral ganglion, and surrounding
mesenchyme, so we dissected the hind-brain region for
expression analysis. Because the Eya1bor mutant mRNA
retains a portion of intron 7 due to the IAP insertion, we
designed primers spanning the region between exons 7 and
8 such that only the wild-type transcript would be amplified.
To determine the total amount of wild-type and mutant Eya1
transcript, we also designed primers spanning the region
between exons 6 and 7. Comparing expression levels of Eya1
in the Mead1 and Mead2 congenic strains to C3HeB/FeJ-
Eya1bor/bor, we observed no significant difference in the levels
of Eya1 expression using quantitative real-time RT-PCR (Fig.
5). This suggested that suppressor effects of Mead1 and
Mead2 were not the result of Eya1 posttranscriptional
processing, as was discovered for Nxf1.
Discussion
The effects of mutations in the mouse ortholog Eya1 on
inner ear development have been described by us and others
[6]. We have described a hypomorphic allele resulting from
an IAP insertion (Eya1bor/bor) in which the adult homozygous
phenotype consists of severe cochlear dysmorphogenesis and
absence of the cochlear and vestibular nerves [6]. When these
original mutants were outcrossed to other strains, such as
CAST/Ei and C57BL/6J, several F2-Eya1bor/bor progeny
showed dramatically improved phenotypes, most notably,
improved hearing and enhanced cochlear coiling. In this
study, we analyzed ABR thresholds and cochlear turns as
traits in F2-Eya1bor/bor mice from a C3HeB/FeJ and C57BL/
6J intercross. Two markers (D4Mit104 and D12Mit283)
were found to be highly associated with both traits, sug-
gesting that the same genes are responsible for both modi-
fications (Table 1). We also observed a correlation between
cochlear turns and ABR thresholds in Mead1 congenic mice.
When carrying one C57BL/6J Mead1 allele, congenic
Fig. 3. Cochlear modifications in the F2 Eya1bor/bor mice from a C57BL/6J × C3HeB/FeJ-Eya1bor/+ intercross as shown by paint injection. (A) Wild-type C3HeB/FeJ
demonstrating the normal 13/4 turns. (B) The C3HeB/FeJ-Eya1bor/bor cochlea is cystic with no visible round window. (C–F) F2 Eya1bor/bor mice from a C57BL/
6J × C3HeB/FeJ-Eya1bor/+ intercross with (C) no modification, (D) 1/2 cochlear turn, (E) 1 cochlear turn, and (F) 13/4 cochlear turns. Arrowhead, oval window.
Arrow, round window.
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deaf. However, when carrying two copies of the C57BL/6J
Mead1 allele, the mutants formed 1–1 1/4 cochlear turns and
the hearing of these mice was partially preserved (70–85 dB).
Mead2 was mapped to an 11-cM (95% confidence interval)
region considering ABR thresholds as the quantitative trait.
Utilizing our congenic strains for the QTL analysis, we ob-
served a 4.4-cM region within the original 11 cM that par-
tially rescued the cochlear dysmorphogenesis in the C3HeB/
FeJ-Eya1bor/bor mice. These data suggest that a gene within
this interval in the C57BL/6J genome is suppressing the
hearing loss phenotype, at least partially, by enhancing coch-
lear development.
The modifications of cochlear development and hearing
improvement are not parallel. In F2-Eya1bor/bor mice, both
Mead1 and Mead2 explain approximately the same amount of
variation in hearing (19%). However, Mead1 had a much
stronger effect (57% variation) on cochlear turns than Mead2
(16% variation), which was confirmed in the congenic strains.
There are two potential explanations for this difference. First,
the modifiers may have developmental effects on the middle
ear structures and/or the cochlear nerves, as well as cochlear
morphogenesis. The ABR threshold represents the overall
function of the sound processing pathway from the external
ear to the brain stem. This includes sound transduction
through the middle ear, translation of the sound into nerveimpulses in the cochlea, and the transmission of this impulse
to the brain stem via the cochlear nerve. Based upon the
hearing and morphological data presented, Mead1 could have
a stronger modification on cochlear coiling, while Mead2 may
exert a greater influence on the middle ear conductive
apparatus and/or the cochlear nerve, both mechanisms
improving hearing. The middle ear defect was well
documented in Eya1 knockout mice, with several hetero-
zygotes demonstrating an associated conductive hearing loss
[4]. Similarly, the loss of acoustic ganglion cells was
observed in both the Eya1 knockout mice [4] and the
Eya1bor/bor hypomorph [9]. Although the middle ear function
and morphology were not systematically examined in the
Eya1bor/bor mice, small stapes were observed in some mutants
and, occasionally, unabsorbed mesenchymal tissue was found
filling the tympanic cavity. Another possible explanation is
that there are other loci interacting with Mead1 and Mead2.
There exist other modifier loci in this C3HeB/FeJ and
C57BL/6J cross, since Mead1 and Mead2 combined can
explain only 35% of the total hearing rescue. The contribu-
tions of these weaker modifiers could be very complicated
and likely explain the alteration of the phenotype in our
congenic strains.
Historically, one reason for the difficulty in modifier gene
identification is the loss of the trait of interest during fine-
mapping. These QTLs lose power or phenotypes are “lost”
Fig. 4. Genetic mapping using congenic mice places (A) Mead1 in a 5.4-cM region of chromosome 4 and (B) Mead2 in a 4.4-cM region of chromosome 12 by
assessing cochlear turns in Eya1bor/bor mice. In (A), each open square represents one C57BL/6J allele (heterozygous) in the Mead1 interval or C57BL/6J phenotype
(cochlear turns). In (B), each open square represents two C57BL/6J alleles (homozygous) in theMead2 interval or C57BL/6J phenotype (cochlear turns). The physical
positions (Mb) of the markers are from the NCBI mouse genome database, and the genetic positions (cM) are from the Broad Institute. Total numbers of Eya1bor/bor
mice are indicated at the top in each category.
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donor regions outside the loci of interest that contribute to the
phenotype, as was the case during the generation of our Mead1
and Mead2 congenic strains. The suppression of the hearing
loss phenotype, originally observed in the F2-Eya1bor/bor,
is absent in the congenic strains. However, when we bred
Mead1 congenic strains to homozygosity for the C57BL/6J
allele, we observed partially restored hearing (70–85 dB) in the
Eya1bor/bor mutants. We did not observe hearing rescue in
Mead2 congenic lines though, suggesting that interactions with
other loci (Mead1 or others) are needed to overcome a
“threshold.”
The phenotype being rescued in this study resulted from
an IAP insertion. The mutant mice transcribe normal Eya1
mRNA as well as nonfunctional mutant isoforms. Through
positional complementation, Nxf1 was identified as a
modifier that suppressed alleles, such as Eya1bor, through
the preferential elevation of levels of correctly processedmRNA [8]. Specifically, in the presence of CAST/Ei alleles
of Nxf1, Eya1bor mRNA levels were reduced while wild-
type Eya1 mRNA levels were increased [8]. Furthermore,
CAST/Ei alleles for Nxf1 had a semidominant effect on
ABR thresholds and cochlear development in homozygous
Eya1bor/bor mice.
In this study, we measured wild-type Eya1 mRNA levels
in E10.5 mouse embryos by quantitative PCR, and we found
that neither total Eya1 mRNA nor wild-type Eya1 mRNA was
significantly changed in the congenic Eya1bor/bor mice
homozygous for the C57BL/6J Mead1 or Mead2 alleles.
These data suggest that it is very likely that Mead1 and
Mead2 are involved directly in inner ear development,
possibly by interacting with certain components of the
conserved Eya1–Six1 pathway. We are in the process of
narrowing the critical regions of Mead1 and Mead2 in
subcongenic strains. Candidate gene analysis is currently
under way. No known Eya1- or Six1-interacting genes reside
Fig. 5. thEya1 mRNA levels in the hind-brain region of E10.5 embryos
measured by quantitative PCR. Expression levels were measured in the control
strain C3HeB/FeJ-Eya1bor/bor, in the congenic Eya1bor/bor mice homozygous for
C57BL/6Mead1, and in the congenic Eya1bor/bormice homozygous for C57BL/
6 Mead2. (A) Relative expression of wild-type Eya1 transcript. (B) Relative
expression levels of total Eya1 transcript (referred to as Eya1-WT + Bor),
consisting of both wild-type and mutant transcripts. Data are presented as
means ± SEM; n = 4 in each group.
Table 1
Two major QTLs at D4Mit104 and D12Mit283





Mead1 ABR D4Mit104 12.0 b 19 9 cMc
Cochlear turns D4Mit104 15.8 d 56 9 cMc
Mead2 ABR D12Mit283 12.1 b 19 11 cM
Cochlear turns D12Mit283 3.3 d 16 37 cM
a CI, confidence interval.
b Lod limit is 2.8 for significance (p = 0.05) and 4.7 for high significance
(p = 0.001).
c Calculated intervals are 11 cM, but D4Mit104 is only 2.2 cM from telomere.
d Lod limit is 3.1 for significance (p = 0.05) and 5.3 for high significance
(p = 0.001).
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Mead1 and Mead2 will lead to novel information about the
Eya1 signaling pathway in ear development and about the
genetics of variable expressivity in BOR syndrome.
Materials and methods
Mouse crosses
All mice used in this study were originally obtained from The Jackson
Laboratory. For the intercross, Eya1bor/+ F1 progeny from breeding pairs of
C3HeB/FeJ-Eya1bor/+ and C57BL/6J were intercrossed to produce Eya1bor/bor
F2 progeny. For the congenic lines, a marker-assisted breeding approach was
used as reported [10]. Briefly, Eya1bor/+ F1 progeny from breeding pairs of
C3HeB/FeJ-Eya1bor/+ and C57BL/6J were serially backcrossed to C3HeB/FeJ-
Eya1bor/+. In each generation, Eya1bor/+ males were subjected to marker test in
regions that are heterozygous for C57BL/6J and C3HeB/FeJ, and two or three
mice with the least amount of these heterozygous regions were chosen as
breeders for the next generation. The congenic lines were generated after five or
six backcrosses.
ABR phenotyping
An Auditory Evoked Response Workstation (TDT; Alachua, FL, USA) was
used to obtain ABR thresholds for click stimuli. ABR was performed at the age
of 6–8 weeks, and each ear was tested separately.
Cochlear clearing and paint injection
Adult inner ears were harvested and fixed in PBS-buffered 4% formaldehyde
overnight. Inner ears were dehydrated through serial ethanol washes (70, 95, and
100%) and cleared with methyl salicylate (Sigma). Cochleas were dissected, and
cochlear turns from oval window to apex were counted directly under a light
microscope and categorized at an increment of one-quarter. A cochlea is
categorized as having one-quarter of turn when it meets the following criteria:
(a) has an identifiable round window; (b) two tunnels formed in the cochlea withone tunnel connecting to the oval window and another to the round window; (c)
the junction of the two tunnels (apex in normal cochleas) is away from the inner
ear axis with an angel of more than 45° (a half-quarter). For paint injection, 10%
enamel paint (Glidden; semigloss interior/exterior oil/alkyd) in methyl salicylate
was perfused into the cochlea through the oval window to fill the perilymphatic
space that normally surrounds the membranous labyrinth [11].
Genotyping
For the Eya1bor allele, tails (2–5 mm) from 6- to 12-day-old pups were
digested overnight with proteinase K (0.4 mg/ml) in 50 μl PBND buffer (50
mM KCl, 10 mM Tris–HCl, pH 8.3, 2.5 mM MgCl2, 0.1 mg/ml gelatin, 0.45%
v/v NP-40, 0.45% v/v Tween 20). One microliter of the digestion was used in a
10-μl PCR containing 0.2 mM each primer, 0.2 mM dNTP, and 0.1 unit
Titanium Taq DNA polymerase (Clontech). The reactions were subjected to
the following PCR program: initial denaturation for 5 min at 95°C; 30 s
at 94°C, 15 s at 60°C, 30 s at 72°C for 36 cycles, followed by a 10-min
extension at 72°C. The sequences of the primers were as follows: mutant
forward primer, 5′-TAAGCAGACCTGACAAGAGGCATTGTTT-3′; wild-
type forward primer, 5′-GAACGCGTCGAATAACAGGTAGGAAAGT-3′;
reverse primer, 5′-TTGGGTCCTAAGTCTACCTTATCCACCAC-3′.
For whole genome scan, DNAwas extracted from the external ear using the
DNeasy kit (Qiagen). Dye-labeled SSLP markers (Applied Biosystems or
Integrated DNA Technologies) that were polymorphic between C57BL/6J and
C3HeB/FeJ were selected at ~25-cM intervals across the mouse genome. For
PCR amplification, 30 ng DNAwas used in a 6-μl reaction as above. The PCR
program was as follows: initial denaturation for 5 min at 95°C; 30 s at 94°C, 15 s
at 60°C (decrease 0.5°C each cycle), 50 s at 72°C for 20 cycles; 30 s at 94°C, 15
s at 52°C, 50 s at 72°C for another 20 cycles; followed by a 15-min extension at
72°C. PCR products from different primers were pooled according to the size
and labeling dye, and genotyping electrophoreses were run on an ABI 377
machine (Applied Biosystems).
QTL analysis
Map Manager QTXb20 was used to identify QTLs [12]. ABR thresholds
were categorized in 14 groups beginning with 0 for deafness and 1–13 as the
subsequent groups of thresholds ranging from 90 to 30 dB in 5-dB increments.
Cochlear turns were categorized at 1/4-turn increments. The better ABR
threshold or cochlear turn of two ears was used to represent the mouse.
Quantitative real-time RT-PCR
Total RNAwas isolated from the hind-brain region of E10.5 embryos using
TRIzol Reagent (Invitrogen) and treated with DNase prior to RT-PCR. For
cDNA synthesis, the Superscript First-Strand Synthesis System for RT-PCR
(Invitrogen) with random hexamer primer was used. For quantitative PCR, the
SYBR Green PCR Master Mix (Applied Biosystems) was used. The
manufacturer's protocols were followed. Briefly, 1 μl of first-strand cDNA
results from 3% of the original hind-brain region was used in a 20-μl qPCR,
308 H. Niu et al. / Genomics 88 (2006) 302–308which contains primers at 0.1 mM final concentration. The PCRs were
performed on an ABI 7700 machine (Applied Biosystems). The reactions were
subjected to the following PCR program: initial denaturation for 10 min at 95°C;
15 s at 95°C, 1 min at 65°C for 40 cycles. The melting curve was analyzed after
each run for amplification specificity. Standard curves were run for each primer
set and expression levels were normalized against the β-actin gene. Each sample
was run in duplicate with a sample size of 4. The primer sequences for Eya1 and
β-actin were the following: wild-type Eya1, F, 5′-CCACCAATGCCACTTAC-
CAAC-3′, R, 5′-CGTGACTTCCCATCTGAACCT-3′; all Eya1 transcripts, F,
5′-CCGGATTCAACAGTTCACAGCA-3′, R, 5′-TTGGTAAGTGG-
CATTGGTGGAC-3′; β-actin, F, 5′-GGCATTGTTACCAACTGGGACGA-3′,
R, 5′-ATGGCTGGGGTGTTGAAGGTCT-3′.
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